Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 118 participants.
Also called NCT01385176
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 118 participants
- Sponsor
- Registry
-
NCT01385176
-
- Other papers using this trial's data
- Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial
- Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT01385176. Randomized; double masking; primary purpose treatment. Start 2011-09-21 (actual); primary completion 2014-05 (actual). Results posted on 2020-01-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
- Acronym
- NECTAR-HF
- Condition
- Heart Failure
- Condition
- Congestive Heart Failure
- Intervention (Device)
- Implant of investigational device system
- Intervention (Procedure)
- Titration during the randomization phase
- Intervention (Procedure)
- Titration after the randomization phase
- Intervention (Diagnostic test)
- Blood Draw
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01385176- Content hash
81960dfa4ed320520f0b86abde61b020707e6e0cd405872811e1bb36620b114b